It's not for me either.
I don't think that makes it bad.
Just built to a price point that makes economic sense.
And for market segments where $1500 is not a non-starter.
I don't think that makes it bad.
Just built to a price point that makes economic sense.
And for market segments where $1500 is not a non-starter.
I don’t think there is anything wrong with the price. It’s not a lifesaving drug or something like that.